These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7789015)

  • 21. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ; Coles HJ; Stern CM; Pearson TC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin in anemia of prematurity.
    Whitehall JS; Patole SK; Campbell P
    Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
    Abels RI
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Decreased transfusions in preterm infants with anemia treated with erythropoietin].
    López-Catzín JF; Bolado-García PB; Gamboa-López GJ; Medina-Escobedo CE; Cambranes-Catzima LR
    Rev Med Inst Mex Seguro Soc; 2016; 54(5):576-80. PubMed ID: 27428338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prevention of anemia in premature infants: the role of recombinant human erythropoietin in a level III neonatology department].
    Klosowski S; Kongolo G; Morisot C; Thelliez P; Djebara A; Deroubaix P
    Arch Pediatr; 1999 May; 6(5):592-4. PubMed ID: 10370824
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant erythropoietin in very-low-birth-weight infants.
    Beck D; Calame A; Masserey E
    N Engl J Med; 1994 Sep; 331(10):676-7; author reply 677-8. PubMed ID: 8052281
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant erythropoietin and blood transfusion in selected preterm infants.
    Meyer MP; Sharma E; Carsons M
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F41-5. PubMed ID: 12496225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for using recombinant human erythropoietin to treat the anemia of prematurity.
    Phibbs RH; Shannon K; Mentzer WC
    Contrib Nephrol; 1989; 76():324-8; discussion 328-9. PubMed ID: 2684531
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant erythropoietin in very-low-birth-weight infants.
    Carnielli VP; Da Riol R; Montini G
    N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8052282
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
    Phibbs RH; Shannon KM; Mentzer WC
    Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating erythroid progenitors in the anemia of prematurity.
    Shannon KM; Naylor GS; Torkildson JC; Clemons GK; Schaffner V; Goldman SL; Lewis K; Bryant P; Phibbs R
    N Engl J Med; 1987 Sep; 317(12):728-33. PubMed ID: 3627181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing patterns of care in the management of anemia.
    Henry DH
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):3-7. PubMed ID: 1615338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
    Christensen RD; Hunter DD; Ohls RK
    J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants].
    Rabbani F
    Lik Sprava; 2002; (3-4):81-4. PubMed ID: 12145901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
    Phibbs RH
    Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
    Keyes WG; Donohue PK; Spivak JL; Jones MD; Oski FA
    Pediatrics; 1989 Sep; 84(3):412-7. PubMed ID: 2771544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?
    Meyer MP; Haworth C; McNeill L
    S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human erythropoietin as a treatment for anemia of prematurity.
    Downey P
    J Perinat Neonatal Nurs; 1997 Dec; 11(3):57-68. PubMed ID: 9451192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.